Dysregulation of GH axis after Roux-en-Y gastric bypass
The Journal of Clinical Endocrinology & Metabolism · 21.10.2026
DOI: 10.1210/clinem/dgag428 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 21.10.2026. Verfasst von Lei Pei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Division, Joslin Diabetes Center, Boston, MA. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH, Diabetes Research Center, Joslin Diabetes Center.
Abstract (Originalsprache)
Context
Bariatric metabolic surgery has potent effects on glucose metabolism, with increases in insulin sensitivity and insulin secretion contributing to both improved glycemia and/or remission of type 2 diabetes and development of hypoglycemia (postbariatric hypoglycemia [PBH]). Previous studies suggest GH secretion and/or action are altered after bariatric surgery and may mediate early postsurgical improvements in glycemic control. Given the importance of GH signaling in glucose metabolism, we hypothesized that reductions in GH signaling and/or action could also contribute to PBH.
Objective
Assessment of GH responses to 2 distinct stimuli: (1) experimental hypoglycemia induced by hyperinsulinemic hypoglycemic clamp and (2) glucagon stimulation.
Setting
Academic medical center.
Participants
Individuals with history of Roux-en-Y gastric bypass (RYGB) with PBH (n = 20), without hypoglycemia (n = 20), and weight-matched nonsurgical controls (n = 10). Main outcomes GH responses were assessed (1) during experimental hypoglycemia and (2) after glucagon stimulation. Plasma GH receptor and insulin-like growth factors and binding proteins were also measured.
Results
Glucagon-stimulated GH levels were 5 to 6 times higher in both post-RYGB groups vs controls at 120 minutes: control: 481 ± 137 pg/mL; RYGB without hypoglycemia 2521 ± 678 pg/mL; PBH: 3018 ± 137 pg/mL (control vs RYGB without hypoglycemia P = .02; control vs PBH; P = .005). In contrast, PBH participants showed lower GH responses to experimental hypoglycemia. Additionally, plasma GH receptor and IGF-1 levels were reduced in PBH vs controls.
Conclusion
We find that plasma GH response to 2 distinct experimental stimuli differed in participants with a history of bariatric surgery. However, these patterns did not differ in those with and without PBH. Further studies will be required to determine if tissue-level alterations in GH action contribute to improved glycemic control after bariatric surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Division, Joslin Diabetes Center, Boston, MA.
- Harvard Medical School, Boston MA.
- Division of Endocrinology, Diabetes and Hypertension; Brigham and Women's Hospital, Boston, MA.
ORCID-Profile: Mary-Elizabeth Patti
Förderung
- NIH
- Diabetes Research Center
- Joslin Diabetes Center
Zitieren
APA
Pei, L., Cummings, C., Saeed, H., Amore, A., Farahmandsadr, M., Sheehan, A., Ferraz-Bannitz, R., Simonson, D. C., & Patti, M. E. (2026). Dysregulation of GH axis after Roux-en-Y gastric bypass. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag428
Vancouver
Pei L, Cummings C, Saeed H, Amore A, Farahmandsadr M, Sheehan A, et al. Dysregulation of GH axis after Roux-en-Y gastric bypass. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag428
BibTeX
@article{Pei2026,
author = {Pei, Lei and Cummings, Cameron and Saeed, Hamayle and Amore, Alessandra and Farahmandsadr, Maryam and Sheehan, Amanda and Ferraz-Bannitz, Rafael and Simonson, Donald C and Patti, Mary-Elizabeth},
title = {Dysregulation of GH axis after Roux-en-Y gastric bypass},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag428}
}
EUVIMED